Abacus FCF Advisors’s Eli Lilly LLY Stock Holding History

Abacus FCF Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,057	Closed	-$2.18M	–	171
2023 Q3	$2.18M	Sell	4,057 -111	-3%	-$57.2K	1.16%	15
2023 Q2	$1.95M	Sell	4,168 -1,414	-25%	-$593K	0.99%	27
2023 Q1	$1.92M	Sell	5,582 -518	-8%	-$175K	1.03%	25
2022 Q4	$2.23M	Sell	6,100 -135	-2%	-$47.9K	1.46%	8
2022 Q3	$2.02M	Sell	6,235 -450	-7%	-$143K	1.39%	8
2022 Q2	$2.17M	Sell	6,685 -4,825	-42%	-$1.45M	1.33%	12
2022 Q1	$3.3M	Buy	+11,510	New	+$2.96M	1.1%	15
2019 Q3	–	Sell	-9,377	Closed	-$1.04M	–	103
2019 Q2	$1.04M	Sell	9,377 -1,065	-10%	-$125K	0.85%	86
2019 Q1	$1.35M	Buy	10,442 +435	+4%	+$52.9K	1.05%	44
2018 Q4	$1.16M	Buy	+10,007	New	+$1.12M	1.06%	38

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Abacus FCF Advisors's LLY Position: Q4 2023 in Review

Abacus FCF Advisors sold out of Eli Lilly (LLY) in Q4 2023, closing a stake of 4,057 shares — an estimated $2.18M sold.

Abacus FCF Advisors first reported a position in LLY in Q4 2018 and held it in 10 quarters. The position peaked at $3.3M in Q1 2022. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

Abacus FCF Advisors reported no remaining Eli Lilly position as of Q4 2023 after selling out during the quarter.
Abacus FCF Advisors sold 4,057 Eli Lilly shares in Q4 2023, an estimated $2.18M.
Abacus FCF Advisors first reported a position in Eli Lilly in Q4 2018 and held it in 10 quarters.
Abacus FCF Advisors's Eli Lilly position peaked at $3.3M in Q1 2022.
3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Abacus FCF Advisors's 13F filing for Q4 2023, filed 4 Jan 2024.